Akero Therapeutics Inc (NASDAQ:AKRO)

37.81
Delayed Data
As of 3:59pm ET
 -2.49 / -6.18%
Today’s Change
7.52
Today|||52-Week Range
54.88
-31.00%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Akero Therapeutics Inc have a median target of 59.00, with a high estimate of 65.00 and a low estimate of 48.00. The median estimate represents a +56.04% increase from the last price of 37.81.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Akero Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.70
Sales
$0.00
Reporting Date
May 17

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -41.84%
 
 
 
 
 
 
Growthannually -12.78%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.